Author(s) :
Jose Ma. H. Zaldarriaga1, Julius Cezar P. Rojales1, Kathleen Jane U. Cortez1, Janet M. Martinez1, Gaudencio P. Vega1
1Department of Radiation Oncology, St. Luke’s Medical Center, Republic of the Philippines
Corresponding author: Jose Ma. H. Zaldarriaga, Email: jmaphzaldarriaga@stlukes.com.ph
Publication History: Received - , Revised - , Accepted - , Published Online - 1 May 2024.
Copyright: © The author(s). Published by Casa Cărții de Știință.
User License: Creative Commons Attribution – NonCommercial (CC BY-NC)
Share
Abstract
Male breast cancer (MBC) is a rare disease with potentially distinct biological and clinical differences compared to its more common female counterpart. It accounts for less than 1% of all breast cancer cases, less than 1% of all male cancers, and less than 0.1% of all cancer deaths in men.
This is a case series of seven elderly gentlemen diagnosed with MBC. All patients underwent trimodality treatment of neoadjuvant chemotherapy, followed by mastectomy, capped by radiation therapy and adjuvant tamoxifen. The cases are juxtaposed and integrated with the current literature on male breast cancer.